Ro 3-0419

Ro 3-0419
[[File:|frameless|220px|alt=|Chemical structure of Ro 3-0419]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Ro 3-0419 is a chemical compound that has been studied for its potential pharmacological effects. It is part of a class of compounds known as benzodiazepines, which are known for their effects on the central nervous system, particularly their ability to modulate the GABA_A receptor.

Pharmacology

Ro 3-0419 is a derivative of the benzodiazepine class, which are known to act as positive allosteric modulators of the GABA_A receptor. This receptor is a type of ligand-gated ion channel that, when activated, allows chloride ions to enter the neuron, leading to hyperpolarization and decreased neuronal excitability. Benzodiazepines enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at this receptor, leading to sedative, anxiolytic, muscle relaxant, and anticonvulsant effects.

Chemical Structure

The chemical structure of Ro 3-0419 is characterized by the presence of a benzodiazepine core, which is a fusion of a benzene ring and a diazepine ring. The specific substitutions on this core structure can significantly affect the pharmacological properties of the compound.

Research and Development

Ro 3-0419 was developed as part of a series of compounds aimed at exploring the structure-activity relationships of benzodiazepines. The goal was to identify compounds with specific therapeutic profiles, such as enhanced anxiolytic effects with reduced sedative properties.

Clinical Applications

While Ro 3-0419 itself may not be used clinically, the study of such compounds contributes to the understanding of benzodiazepine pharmacology and the development of new therapeutic agents. Benzodiazepines are widely used in the treatment of anxiety disorders, insomnia, muscle spasms, and seizures.

Safety and Toxicology

As with other benzodiazepines, potential side effects of compounds like Ro 3-0419 may include drowsiness, dizziness, and impaired coordination. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon cessation.

Also see

• Benzodiazepine
• GABA_A receptor
• Anxiolytic
• Sedative
• Pharmacology

Benzodiazipines

• Alprazolam
• Chlordiazepoxide
• Diazepam (Oral)
• Estazolam
• Flurazepam
• Lorazepam
• Midazolam
• Oxazepam
• Quazepam
• Temazepam
• Triazolam

Anticonvulsants Drugs

• Clobazam
• Clonazepam
• Clorazepate
• Diazepam (Intravenous)

Anticonvulsants, and Benzodiazepines]

Template:GABAergic drugs

• 

  Ro 3-0419